MODIFIED GLP-1 RECEPTOR AGONISTS AND THEIR PHARMACOLOGICAL METHODS OF USE

Details for Australian Patent Application No. 2003273300 (hide)

Owner BAYER PHARMACEUTICALS CORPORATION

Inventors PAN, Clark; WHELAN, James, P.

Pub. Number AU-A-2003273300

PCT Number PCT/US03/28093

PCT Pub. Number WO2004/022004

Priority 60/439,369 09.01.03 US; 60/408,696 06.09.02 US

Filing date 4 September 2003

Wipo publication date 29 March 2004

Event Publications

5 February 2004 Complete Application Filed

  Priority application(s): 60/439,369 09.01.03 US; 60/408,696 06.09.02 US

13 May 2004 Application Open to Public Inspection

  Published as AU-A-2003273300

14 July 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003273301-Three piece basket carrier

2003273299-Methods of preventing or treating cell malignancies by administering CD2 antagonists